Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

  • Bernardim, Barbara
  • Corzana, Francisco
  • Jiménez-Osés, Gonzalo
  • Bernardes, Gonçalo J. L.
This work is licensed under a Creative Commons Attribution 4.0 International License.-- et al., Maleimides remain the reagents of choice for the preparation of therapeutic and imaging protein conjugates despite the known instability of the resulting products that undergo thiol-exchange reactions in vivo. Here we present the rational design of carbonylacrylic reagents for chemoselective cysteine bioconjugation. These reagents undergo rapid thiol Michael-addition under biocompatible conditions in stoichiometric amounts. When using carbonylacrylic reagents equipped with PEG or fluorophore moieties, this method enables access to protein and antibody conjugates precisely modified at pre-determined sites. Importantly, the conjugates formed are resistant to degradation in plasma and are biologically functional, as demonstrated by the selective imaging and detection of apoptotic and HER2+ cells, respectively. The straightforward preparation, stoichiometric use and exquisite cysteine selectivity of the carbonylacrylic reagents combined with the stability of the products and the availability of biologically relevant cysteine-tagged proteins make this method suitable for the routine preparation of chemically defined conjugates for in vivo applications., We thank FAPESP (2012/22274-2; BEPE 2015/07509-1 to B.B., and 2013/25504-1 for A.C.B.B.), Xunta de Galicia (M.J.M.), FCT Portugal (FCT Investigator to G.J.L.B.; SFRH/BPD/103172/2014 Postdoctoral fellowship to P.M.S.D.C.; SFRH/BD/111556/2015 PhD Studentship to I.S.A.), the EU (Marie-Sklodowska Curie ITN Protein Conjugates), the EPSRC, MECD (‘Salvador Madariaga’ mobility grant PRX15/00638 to F.C.) and MINECO (CTQ2015-70524-R and RYC-2013-14706 to G.J.-O.) for funding. . G.J.L.B. is a Royal Society University Research Fellow and the recipient of an European Research Council Starting Grant (TagIt)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Azabicyclic vinyl sulfones for residue-specific dual protein labelling

  • Gil de Montes,Enrique
  • Jiménez-Moreno, Ester
  • Oliveira, Bruno L.
  • Navo, Claudio D.
  • Cal, Pedro M. S. D.
  • Jiménez-Osés, Gonzalo
  • Robina, Inmaculada
  • Moreno-Vargas, Antonio J.
  • Bernardes, Gonçalo J. L.
We have developed [2.2.1]azabicyclic vinyl sulfone reagents that simultaneously enable cysteine-selective protein modification and introduce a handle for further bioorthogonal ligation. The reaction is fast and selective for cysteine relative to other amino acids that have nucleophilic side-chains, and the formed products are stable in human plasma and are moderately resistant to retro Diels–Alder degradation reactions. A model biotinylated [2.2.1]azabicyclic vinyl sulfone reagent was shown to efficiently label two cysteine-tagged proteins, ubiquitin and C2Am, under mild conditions (1–5 equiv. of reagent in NaPi pH 7.0, room temperature, 30 min). The resulting thioether-linked conjugates were stable and retained the native activity of the proteins. Finally, the dienophile present in the azabicyclic moiety on a functionalised C2Am protein could be fluorescently labelled through an inverse electron demand Diels–Alder reaction in cells to allow selective apoptosis imaging. The combined advantages of directness, site-specificity and easy preparation mean [2.2.1]azabicyclic vinyl sulfones can be used for residue-specific dual protein labelling/construction strategies with minimal perturbation of native function based simply on the attachment of an [2.2.1]azabicyclic moiety to cysteine., We thank the Universidad de Sevilla (E. G. M. short stay PP2017- 8144), the Spanish Ministry of Education, Culture and Sport under the FPU program (E. G. M.), the Spanish Ministry of Economy and Competitiveness (CTQ2016-77270-R to A. J. M.-V., E. G. M. and I. R. and CTQ2015-70524-R and RYC-2013-14706 to G. J.-O. and C. D. N.), the EU (Marie-Sklodowska Curie ITN Protein Conjugates to G. J. L. B., GA No. 675007; Marie Sklodowska Curie IEF to B. L. O., GA No. 702574 and to E. J. M., GA No. 701473), FCT Portugal (FCT Investigator to G. J. L. B., IF/00624/2015 and postdoctoral fellowship SFRH/BPD/ 103172/2014 to P. M. S. D. C.), and the EPSRC (grant EP/ M003647/1 to G. J. L. B.) for funding. We thank Dr Andr´e Neves and Prof. Kevin Brindle for providing the C2Am protein; Dra. Elena Moreno Clavijo for her helpful discussions, and Dr Vikki Cantrill for her help with the preparation and editing of this manuscript. We also thank CITIUS for NMR and mass spectrometry assistance and BERONIA (Universidad de La Rioja) for computer support. G. J. L. B. is a Royal Society University Research Fellow (UF110046 and URF\R\180019) and the recipient of a European Research Council Starting Grant (TagIt, GA No. 676832)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stable Pyrrole-Linked Bioconjugates through Tetrazine-Triggered Azanorbornadiene Fragmentation

  • Gil de Montes, Enrique
  • Istrate, Alena
  • Navo, Claudio D.
  • Jiménez-Moreno, Ester
  • Hoyt, Emily A.
  • Corzana, Francisco
  • Robina, Inmaculada
  • Jiménez-Osés, Gonzalo
  • Moreno-Vargas, Antonio J.
  • Bernardes, Gonçalo J. L.
An azanorbornadiene bromovinyl sulfone reagent for cysteine-selective bioconjugation has been developed. Subsequent reaction with dipyridyl tetrazine leads to bond cleavage and formation of a pyrrole-linked conjugate. The latter involves ligation of the tetrazine to the azanorbornadiene-tagged protein through inverse electron demand Diels-Alder cycloaddition with subsequent double retro-Diels-Alder reactions to form a stable pyrrole linkage. The sequence of site-selective bioconjugation followed by bioorthogonal bond cleavage was efficiently employed for the labelling of three different proteins. This method benefits from easy preparation of these reagents, selectivity for cysteine, and stability after reaction with a commercial tetrazine, which has potential for the routine preparation of protein conjugates for chemical biology studies., We thank the Spanish Ministry of Education, Culture and Sport under the FPU program (E.G.M.), the Spanish Ministry of Economy and Competitiveness (CTQ2016-77270-R toA.J.M.-V., E.G.M. and I.R., RTI2018-099592-B-C22 andRYC-2013–14706 to G.J.-O. and RTI2018-099592-B-C21 toF.C.), the EU (Marie-Sklodowska Curie Actions to E.J.M.,GA No. 701473), and FCT Portugal (FCT Investigator toG.J.L.B., IF/00624/2015) for funding. We thank Dr. AndrØNeves and Prof. Kevin Brindle (CRUK Cambridge Institute,UK) for providing the C2Am protein; Dr. S. Massa and Prof.N. Devoogdt (Vrije Universiteit Brussel, Brussels) for thegenerous gift of the HER2-targeting nanobody 2Rb17c, and Dr. Vikki Cantrill for her help with the preparation andediting of this manuscript. We also thank CITIUS for NMRand mass spectrometry assistance and BERONIA (Universidad de La Rioja) for computer support. G.J.L.B. is a Royal Society University Research Fellow (URF\R\180019) recip-ient of a European Research Council Starting Grant (TagIt,GA. 676832)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Controlled In-Cell Generation of Active Palladium(0) Species for Bioorthogonal Decaging

  • Konč, Juraj
  • Sabatino, Valerio
  • Jiménez-Moreno, Ester
  • Latocheski, Eloah
  • Rodríguez Pérez, Laura
  • Day, Jason
  • Domingos, Josiel B.
  • Bernardes, Gonçalo J. L.
Owing to their bioorthogonality, transition metals have become very popular in the development of biocompatible bond cleavage reactions. However, many approaches require design and synthesis of complex ligands or formulation of nanoparticles which often perform poorly in living cells. This work reports on a method for the generation of an active palladium species that triggers bond cleaving reactions inside living cells. We utilized the water-soluble Na2PdCl4 as a simple source of Pd(II) which can be intracellularly reduced by sodium ascorbate to the active Pd(0) species. Once generated, Pd(0) triggers the cleavage of allyl ether and carbamate caging groups leading to the release of biologically active molecules. These findings do not only expand the toolbox of available bioorthogonal dissociative reactions but also provide an additional strategy for controlling the reactivity of Pd species involved in Pd mediated bioorthogonal reactions, This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 676832), the European Commission (Marie-Skłodowska-Curie Actions IEF to E.J.M., Grant agreement No. 701473), FCT Portugal (Stimulus CEECIND/00453/2018 to G.J.L.B) and CAPES PrInt Call – Program for Institutional Internationalization (88887.310560/2018-00). The authors would also like to thank Dr. Vikki Cantrill for her help with the editing of this manuscript and Claudia Flandoli (draw.science) for editing the figures, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

De novo design of potent and selective mimics of IL-2 and IL-15

  • Silva, Daniel-Adriano
  • Marcos, Enrique
  • Garcia, K. Christopher
  • Baker, David
Silva et al., We thank B. Nordstrom, J. Nordstrom, P. Barrier and J. Barrier for the IPD Fund (Budget Number: 68-0341); CONACyT SNI (Mexico), CONACyT postdoctoral fellowship (Mexico) and IPD translational research program to D.-A.S.; NIH MSTP grant T32 GM007266 to S.Y.; JDRF (2-SRA-2016-236-Q-R) to U.Y.U.; la Caixa Fellowship (la Caixa Banking Foundation, Barcelona, Spain) to A.Q.-R.; FCT Portugal Ph.D. studentship to C.L.-A.; European Research Council (ERC StG, grant agreement 676832), FCT Investigator (IF/00624/2015), and the Royal Society (UF110046 and URF\R\180019) to G.J.L.B.; Marie Curie International Outgoing Fellowship (FP7-PEOPLE-2011-IOF 298976) to E.M.; Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship to C.D.W.; Washington Research Foundation to B.D.W.; NIH grant R35GM122543 to F.P.-A.; Mentored Clinical Scientist Development Award 1K08DK114563-01, and the American Gastroenterological Association Research Scholars Award to M.D.; NIH-RO1-AI51321, NIH-RO1-AI51321, Mathers Foundation, Younger Endowed Chair, and Howard Hughes Medical Institute to K.C.G.; and Howard Hughes Medical Institute and Michelson Medical Research Foundation to D.B. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from the Ministry of economy, Industry, and Competitiveness (Government of Spain)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage

  • Companión, I.
  • Guerreiro, A.
  • Mangini, V.
  • Castro-López, J.
  • Escudero-Casao, M.
  • Avenoza, A.
  • Busto, J.H.
  • Castillón, S.
  • Jiménez-Barbero, J.
  • Asensio, J.L.
  • Jiménez-Osés, G.
  • Boutureira, O.
  • Peregrina, J.M.
  • Hurtado-Guerrero, R.
  • Fiammengo, R.
  • Bernardes, G.J.L.
  • Corzana, F.
GalNAc-glycopeptides derived from mucin MUC1 are an important class of tumor-associated antigens. a-O-glycosylation forces the peptide to adopt an extended conformation in solution, which is far from the structure observed in complexes with a model anti-MUC1 antibody. Herein, we propose a new strategy for designing potent antigen mimics based on modulating peptide/carbohydrate interactions by means of O â†'' S/Se replacement at the glycosidic linkage. These minimal chemical modifications bring about two key structural changes to the glycopeptide. They increase the carbohydrate-peptide distance and change the orientation and dynamics of the glycosidic linkage. As a result, the peptide acquires a preorganized and optimal structure suited for antibody binding. Accordingly, these new glycopeptides display improved binding toward a representative anti-MUC1 antibody relative to the native antigens. To prove the potential of these glycopeptides as tumor-associated MUC1 antigen mimics, the derivative bearing the S-glycosidic linkage was conjugated to gold nanoparticles and tested as an immunogenic formulation in mice without any adjuvant, which resulted in a significant humoral immune response. Importantly, the mice antisera recognize cancer cells in biopsies of breast cancer patients with high selectivity. This finding demonstrates that the antibodies elicited against the mimetic antigen indeed recognize the naturally occurring antigen in its physiological context. Clinically, the exploitation of tumor-associated antigen mimics may contribute to the development of cancer vaccines and to the improvement of cancer diagnosis based on anti-MUC1 antibodies. The methodology presented here is of general interest for applications because it may be extended to modulate the affinity of biologically relevant glycopeptides toward their receptors.